To live or not to live - That depends on GAGE?

Cancer Biology and Therapy

Volumn 1, Issue 4, 2002, Pages 388-390

  Emens, Leisha A ^a   Jaffee, Elizabeth M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Cancer antigens; GAGE; Immunotherapy; Testis antigens

Indexed keywords

GAGE7 PROTEIN, HUMAN; TUMOR ANTIGEN; TUMOR PROTEIN;

GENE EXPRESSION REGULATION; HUMAN; IMMUNOTHERAPY; METABOLISM; METHODOLOGY; MULTIMODALITY CANCER THERAPY; MUTATION; NEOPLASM; NOTE; PHYSIOLOGY;

ANTIGENS, NEOPLASM; COMBINED MODALITY THERAPY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOTHERAPY; MUTATION; NEOPLASM PROTEINS; NEOPLASMS;

EID: 1842832300     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.1.4.13     Document Type: Note

References (24)

1. Kirkin AF, Dzhandzhugazyan KN, Zeuthen J. Cancer/testis antigens: structural and immunobiological properties. Cancer Invest 2002; 20:222-36. (Pubitemid 34205490)
2. Lim SH, Austin S, Owen-Jones E, Robinson L. Expression of testicular genes in haematological malignancies. Br J Cancer 1999; 81:1162-4.
3. Scanlan MJ, Gordon CM, Williamson B, Lee S-Y Chen Y-T, Stockert E, et al. Identification of cancer/testis genes by database mining and mRNA expression analysis. Int J Cancer 2002; 98:485-92. (Pubitemid 34208547)
4. Tureci O, Sahin U, Zwick C, Koslowski M, Seitz G, Pfreundschuh M. Identification of a meiosis-specific protein as a member of the class of cancer/testis antigens. Proc Natl Acad Sci USA 1998; 95:5211-6. (Pubitemid 28208577)
5. Ono T, Kurashige T, Harada N, Noguchi Y, Saika T, Niikawa N. Identification of proacrosin binding protein sp32 precursor as a human cancer/testis antigen. Proc Natl Acad Sci USA 2001; 98:3282-7. (Pubitemid 32220837)
6. Ashkenazi A, Dixit VM. Apoptosis control by death and decoy receptors. Curr Opin Cell Biol 1999; 11:255-60. (Pubitemid 29164042)
7. Ashkenazi A, Dixit VM. Death receptors: signaling and modulation Science 1988; 281:1305-8.
8. Lenardo M, Chan KM, Hornung F, McFarland H, Siegel R, Wang J, et al. Mature T lymphocyte apoptosis--immune regulation in a dynamic and unpredictable antigenic environment. Ann Rev Immunol 1999; 17:221-53.
9. Siegel RM, Chan FK-M, Chun HJ, Lenardo MJ. The multifaceted role of fas signaling in immune cell homeostasis and autoimmunity. Nat Immunol 2000; 1:469-74.
10. Cohen PL, Eisenberg RA. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Ann Rev Immunol 1991; 9:243-69.
11. Nagata S. Fas ligand-induced apoptosis. Ann Rev Gen 1999; 33:39-55.
12. Straus SE, Sneller M, Lenardo MJ, Puck J, Strober W. An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome. Ann Int Med 1999; 130:591-601. (Pubitemid 29169388)
13. Landowski TH, Qu N, Buyuksal I, Painter JS, Dalton WS. Mutations in the Fas antigen in patients with multiple myeloma. Blood 1997; 90:4266-70. (Pubitemid 27508431)
14. Gronbaek K, Straten PT, Ralfkiaer E, Ahrenkiel V, Andersen MK, et al. Somatic Fas Mutations in Non-Hodgkin's Lymphoma: Association with Extranodal Disease and Autoimmunity. Blood. 1998; 92:3018-24. (Pubitemid 28492305)
15. Hahne, M., Rimoldi, D., Schroter, M., Romero, P., Schreier, M, et al. Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape. Science 1996; 274:1363-6. (Pubitemid 26391458)
16. Strand S, Hofmann WJ, Hug H, Muller M, Otto G, et al. Lymphocyte apoptosis induced by CD95 (Apo-1/Fas) ligand-expressing tumor cells - a mechanism of immune evasion? Nat Medicine 1996; 2:1361-6.
17. Pitti RM, Marsters SA, Lawrence DA, Roy M, Kishkel FC, et al. Genomic amplification of a decoy receptor for fas ligand in lung and colon cancer. Nature. 1999; 396:699-703. (Pubitemid 29003951)
18. Takeda K, Smyth MJ, Cretney E, Hayakawa Y, Kayagaki N, Yagita H, et al. Critical role for tumor necrosis factor-related apoptosis-inducing ligand in immune surveillance against tumor development. J Exp Med 2002; 195:161-9. (Pubitemid 34461260)
19. Cretney E, Takeda K, Yagita H, Glaccum M, Peschon JJ, Smyth MJ. Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice. J Immunol 2002; 168:1356-61. (Pubitemid 34094506)
20. Kayagaki N, Yamaguchi N, Nakayama M, Kawasaki A, Akiba H, Okumura K, et al. Involvement of TNF-related apoptosis-inducing ligand in human CD4+ T cell-mediated cytotoxicity. J Immunol 1999; 162:2639-47. (Pubitemid 29309284)
21. Zambon A, Mandruzzato S, Parenti A, Macino B, Dalerba P, Ruol A, et al. MAGE, BAGE, and GAGE gene expression in patients with esophageal squamous cell carcinoma and adenocarcinoma of the gastric cardia. Cancer 2001; 91:1882-8.
22. Scarcella DL, Chow CW, Gonzales MF, Economou C, Brasseur F, Ashley DM. Expression of MAGE and GAGE in high-grade brain tumors: a potential target for specific immunotherapy and diagnostic markers. Clin Cancer Res 1999; 5:335-41. (Pubitemid 29085187)
23. Old LJ. Cancer/Testis (CT) antigens - a new link between gametogenesis and cancer. Cancer Immunol 2001; 1:1.
24. Sigalotti L, Coral S, Altomonte M, Natali L, Gaudino G, Cacciotti P, et al. Cancer testis antigens expression in mesothelioma: role of DNA methylation and bioimmunotherapeutic implications. Br J Cancer 2002; 86:979-82. (Pubitemid 34271036)